Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Lansoprazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 92Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amarin complies with Nasdaq bid price Rule
    Amarin complies with Nasdaq bid price Rule

    29 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/29/3070784/18362/en/Amarin-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Requirement.html

    GLOBENEWSWIRE
    29 Apr 2025
    Share Share
    Amarin to Report Q1 2025 Financial Results, Host Call on May 7
    Amarin to Report Q1 2025 Financial Results, Host Call on May 7

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069658/18362/en/Amarin-to-Report-First-Quarter-2025-Financial-Results-and-Host-Conference-Call-on-May-7-2025.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Sebela Pharma Reports Positive Phase 3 Tegoprazan Result in GERD
    Sebela Pharma Reports Positive Phase 3 Tegoprazan Result in GERD

    23 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sebela-pharmaceuticals-announces-positive-topline-results-from-phase-3-triumph-program-of-tegoprazan-in-gerd-302435337.html

    PR NEWSWIRE
    23 Apr 2025
    Share Share
    Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
    Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change

    09 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/09/3058308/18362/en/Amarin-Confirms-Effective-Date-for-1-For-20-ADS-Ratio-Change.html

    GLOBENEWSWIRE
    09 Apr 2025
    Share Share
    Amarin Appoints Michael Torok to Board
    Amarin Appoints Michael Torok to Board

    07 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/07/3056586/18362/en/Amarin-Appoints-JEC-Capital-Partners-Michael-Torok-to-Board-of-Directors.html

    GLOBENEWSWIRE
    07 Apr 2025
    Share Share
    Amarin Shares Data On EPA In Lp(a) Plasma, GLP-1 Combination
    Amarin Shares Data On EPA In Lp(a) Plasma, GLP-1 Combination

    31 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/31/3052239/18362/en/Amarin-Highlights-Recent-Data-Presented-at-ACC-25-Evaluating-Mechanistic-Effects-of-Eicosapentaenoic-Acid-EPA-in-Lp-a-Enriched-Plasma-and-in-Combination-with-GLP-1-Agonist.html

    GLOBENEWSWIRE
    31 Mar 2025
    Share Share